Neoadjuvant Chemotherapy in Combination with Toripalimab Clinical Trials
3 recruitingDrug
Phase 22Phase 31
Showing 1–3 of 3 trials
Recruiting
Phase 2
Neoadjuvant Therapy Combined With Trastuzumab Rezetecan and Toripalimab for HR+/HER2-low Breast Cancer (NEOTORCH-BREAST 08)
HR Positive/HER2 Low Breast Cancer
First Affiliated Hospital of Zhejiang University111 enrolled5 locationsNCT07383818
Recruiting
Phase 2
Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer (NEOTORCH-BREAST01)
HR+/HER2- Breast Cancer
First Affiliated Hospital of Zhejiang University30 enrolled11 locationsNCT06611813
Recruiting
Phase 3
Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer : a Randomized, Open-label, Parallel-controlled, Multi-center Phase III Study (NEOTORCH-BREAST04)
HR+/HER2- Breast Cancer
First Affiliated Hospital of Zhejiang University194 enrolled13 locationsNCT06977893